Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG–PLA micelle
Yanan Shi,1,2,* Wan Huang,1,* Rongcai Liang,1–3 Kaoxiang Sun,2,3 Fangxi Zhang,2,3 Wanhui Liu,2,3 Youxin Li1–31College of Life Science, Jilin University, Changchun, China; 2State Key Laboratory of Long-acting and Targeting Drug Delivery System, Luye Pharmaceutical Co, Ltd,...
Guardado en:
Autores principales: | Shi YN, Huang W, Liang RC, Sun KX, Zhang FX, Liu WH, Li YX |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/002c171b43954946822879cc63ad2285 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
por: Xie J, et al.
Publicado: (2016) -
Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme
por: Sun P, et al.
Publicado: (2020) -
Self-assembled mPEG–PCL-g–PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro
por: Shi S, et al.
Publicado: (2012) -
mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus
por: Yu A, et al.
Publicado: (2017) -
Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
por: A. M. Kudryashova, et al.
Publicado: (2020)